A long way ahead to improve the cost-effectiveness of biomedical research in China.
作者信息
Wáng Yì-Xiáng J, Li Tiantian
机构信息
1 Faculty of Medicine, The Chinese University of Hong Kong, New Territories, Hong Kong SAR, China ; 2 DXY Website, Guanlan Networks (Hangzhou) Co. Ltd., Hangzhou 310052, China.
出版信息
J Thorac Dis. 2015 Mar;7(3):E62-4. doi: 10.3978/j.issn.2072-1439.2015.02.17.
Abstract
摘要
相似文献
1
A long way ahead to improve the cost-effectiveness of biomedical research in China.中国生物医学研究在提高成本效益方面仍有很长的路要走。
J Thorac Dis. 2015 Mar;7(3):E62-4. doi: 10.3978/j.issn.2072-1439.2015.02.17.
2
A Cost-Effectiveness Analysis of Clopidogrel for Patients with Non-ST-Segment Elevation Acute Coronary Syndrome in China.氯吡格雷用于中国非ST段抬高型急性冠状动脉综合征患者的成本效益分析
Adv Ther. 2016 Sep;33(9):1600-11. doi: 10.1007/s12325-016-0375-9. Epub 2016 Jul 11.
3
A mathematical model of biomedical interventions for HIV prevention among men who have sex with men in China.中国男男性行为人群艾滋病预防的医学干预数学模型
BMC Infect Dis. 2018 Nov 28;18(1):600. doi: 10.1186/s12879-018-3516-8.
4
Clopidogrel Versus Aspirin for the Treatment of Acute Coronary Syndrome After a 12-Month Dual Antiplatelet Therapy: A Cost-effectiveness Analysis From China Payer's Perspective.氯吡格雷与阿司匹林治疗双抗血小板治疗 12 个月后的急性冠状动脉综合征：中国支付方视角的成本效果分析。
Clin Ther. 2018 Dec;40(12):2125-2137. doi: 10.1016/j.clinthera.2018.10.018. Epub 2018 Nov 22.
5
Pharma moves ahead cautiously in China.制药公司在中国谨慎前行。
Science. 2005 Jul 29;309(5735):735. doi: 10.1126/science.309.5735.735.
6
[Cost-effectiveness and affordability of strategy for preventing mother-to-child transmission of hepatitis B in China].[中国预防乙型肝炎母婴传播策略的成本效益与可负担性]
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Jul 10;38(7):852-859. doi: 10.3760/cma.j.issn.0254-6450.2017.07.003.
7
Cost-Effectiveness of a Multifaceted Quality Improvement Intervention for Acute Ischemic Stroke in China.中国急性缺血性脑卒中多方面质量改进干预的成本效果分析
Stroke. 2020 Apr;51(4):1265-1271. doi: 10.1161/STROKEAHA.119.027980. Epub 2020 Feb 5.
8
Cost-effectiveness of adding rh-endostatin to first-line chemotherapy in patients with advanced non-small-cell lung cancer in China.中国晚期非小细胞肺癌一线化疗中添加 rh-endostatin 的成本效益。
Clin Ther. 2011 Oct;33(10):1446-55. doi: 10.1016/j.clinthera.2011.09.016. Epub 2011 Oct 11.
9
Cost-Effectiveness of Different Strategies for the Prevention of Venous Thromboembolism After Total Hip Replacement in China.中国全髋关节置换术后不同静脉血栓栓塞预防策略的成本效益分析
Adv Ther. 2017 Feb;34(2):466-480. doi: 10.1007/s12325-016-0460-0. Epub 2016 Dec 20.
10
Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study.固定剂量复方制剂在中国、印度、墨西哥、尼日利亚和南非用于心血管疾病二级预防的成本效益：一项建模研究。
Lancet Glob Health. 2019 Oct;7(10):e1346-e1358. doi: 10.1016/S2214-109X(19)30339-0. Epub 2019 Aug 30.
引用本文的文献
1
Will the science and technology gap between China and USA becomes narrower, wider, or stay in the same in 50 years' time?50年后，中美之间的科技差距会缩小、扩大还是保持不变？
Quant Imaging Med Surg. 2016 Apr;6(2):233-7. doi: 10.21037/qims.2016.03.04.
2
Why China is currently underperforming in medical innovation and what China can do about it?-Part II.为何中国目前在医学创新方面表现欠佳以及中国对此能做些什么？- 第二部分。
Quant Imaging Med Surg. 2015 Jun;5(3):335-9. doi: 10.3978/j.issn.2223-4292.2015.04.03.
本文引用的文献
1
English language usage pattern in China mainland doctors: AME survey-001 initial analysis results.中国大陆医生的英语使用模式：AME调查-001初步分析结果。
Quant Imaging Med Surg. 2015 Feb;5(1):174-81. doi: 10.3978/j.issn.2223-4292.2014.12.05.
2
Hematology research output from Chinese authors and other countries: a 10-year survey of the literature.中国作者与其他国家作者的血液学研究产出：一项为期10年的文献调查
J Hematol Oncol. 2015 Feb 6;8:8. doi: 10.1186/s13045-014-0103-3.
3
Implications of Web of Science journal impact factor for scientific output evaluation in 16 institutions and investigators' opinion.Web of Science 期刊影响因子对 16 家机构和研究人员科学产出评价的影响及意见。
Quant Imaging Med Surg. 2014 Dec;4(6):453-61. doi: 10.3978/j.issn.2223-4292.2014.11.16.
4
Comment on: Zhang Z, et al. Focus on China: should clinicians engage in research? and lessons from other countries. Quant Imaging Med Surg 2014;4:413-25.评论：张Z等人。聚焦中国：临床医生应参与研究吗？及来自其他国家的经验教训。《定量影像医学与外科学》2014年；4：413 - 25。
Quant Imaging Med Surg. 2014 Oct;4(5):430-2. doi: 10.3978/j.issn.2223-4292.2014.10.04.
5
Focus on China: should clinicians engage in research? and lessons from other countries.聚焦中国：临床医生是否应该从事研究？以及其他国家的经验教训。
Quant Imaging Med Surg. 2014 Oct;4(5):413-25. doi: 10.3978/j.issn.2223-4292.2014.10.07.
6
Meta-analysis: principles and procedures.荟萃分析：原理与程序
BMJ. 1997 Dec 6;315(7121):1533-7. doi: 10.1136/bmj.315.7121.1533.
Zotero 插件